David Wilks
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
 | This article is a stub. |
Dr David Wilks is a British researcher and infectious diseases specialist, who will soon be retiring from the Regional Infectious Diseases Unit at Western General Hospital, run by NHS Lothian in Scotland, UK.[1] Dr Wilks is an honorary associate of Edinburgh Medical School.[2]
Notable studies[edit | edit source]
PACE trial: Main trial outcome
- 1999, Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndrome [4] (Abstract)
- 2001, Health-related quality of life in patients with chronic fatigue syndrome: an international study[5] (Abstract)
- 2002, Fatigue[6] (Full text)
- 2002, The role of fear of physical movement and activity in chronic fatigue syndrome.[7] (Full text)
Letters[edit | edit source]
- PACE trial authors' responses
- 2017, Response to the editorial by Dr Geraghty[8] (Full text)
Talks and interviews[edit | edit source]
Online presence[edit | edit source]
- Researchgate
- PubMed
- Website
- YouTube
See also[edit | edit source]
Learn more[edit | edit source]
- FREEDOM OF INFORMATION – CHRONIC FATIGUE CLINIC - NHS Lothian
References[edit | edit source]
- ↑ NHS Scotland (2018). "Western General Hospital | Jobs" (PDF). Retrieved February 17, 2019.
- ↑ "Associate Members & Honorary Staff". The University of Edinburgh. Retrieved February 17, 2019.
- ↑ White, PD; Goldsmith, KA; Johnson, AL; Potts, L; Walwyn, R; DeCesare, JC; Baber, HL; Burgess, M; Clark, LV; Cox, DL; Bavinton, J; Angus, BJ; Murphy, G; Murphy, M; O'Dowd, H; Wilks, D; McCrone, P; Chalder, T; Sharpe, M; The PACE Trial Management Group (March 5, 2011), "Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial", The Lancet, 377 (9768): 823–836, doi:10.1016/S0140-6736(11)60096-2, PMID 21334061
- ↑ Myers, C.; Wilks, D. (January 1, 1999). "Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndrome". Quality of Life Research. 8 (1): 9–16. doi:10.1023/A:1026459027453. ISSN 1573-2649.
- ↑ Hardt, Jochen; Buchwald, Dedra; Wilks, D; Sharpe, M; Nix, W.A; Egle, U.T (August 2001). "Health-related quality of life in patients with chronic fatigue syndrome". Journal of Psychosomatic Research. 51 (2): 431–434. doi:10.1016/S0022-3999(01)00220-3.
- ↑ Wilks, David; Sharpe, Michael (August 31, 2002). "Fatigue". BMJ. 325 (7362): 480–483. doi:10.1136/bmj.325.7362.480. ISSN 0959-8138. PMID 12202331.
- ↑ Silver, A; Haeney, M; Vijayadurai, P; Wilks, D; Pattrick, M; Main, C.J (June 2002). "The role of fear of physical movement and activity in chronic fatigue syndrome". Journal of Psychosomatic Research. 52 (6): 485–493. doi:10.1016/S0022-3999(01)00298-7.
- ↑ White, PD; Chalder, T; Sharpe, M; Angus, BJ; Baber, HL; Bavinton, J; Burgess, M; Clark, LV; Cox, DL; DeCesare, JC; Goldsmith, KA; Johnson, AL; McCrone, P; Murphy, G; Murphy, M; O'Dowd, H; Potts, L; Walwyn, R; Wilks, D (January 2017). "Response to the editorial by Dr Geraghty". Journal of Health Psychology. 22 (9): 1113–1117. doi:10.1177/1359105316688953.
